concept

MOTOR NEURON

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MOTOR NEURON: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

473Connections

28Hypotheses

0Analyses

50Outgoing

50Incoming

0Experiments

0Debates

Summary

MOTOR NEURON is a concept in neurodegeneration research. Key relationships include: causes, co discussed, activates. Associated with ALS, AMYOTROPHIC LATERAL SCLEROSIS, ATAXIA. Connected to 65 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	MOTOR NEURON
Key Genes/Proteins	ACHE, ACTB, AD, aldh1a2, ALS4, AMPK
Related Diseases	ALS, ALZHEIMER'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS, Ataxia
Related Pathways	APOPTOSIS

Pathway Diagram

graph TD
    MOTOR_NEURON["MOTOR NEURON"]
    MOTOR_NEURON -->|"activates"| STING["STING"]
    MOTOR_NEURON -->|"causes"| NEURON["NEURON"]
    MOTOR_NEURON -->|"causes"| NEURONS["NEURONS"]
    MOTOR_NEURON -->|"targets"| MTOR["MTOR"]
    MOTOR_NEURON -->|"interacts"| P62["P62"]
    MOTOR_NEURON -->|"interacts"| SQSTM1["SQSTM1"]
    MOTOR_NEURON -->|"interacts"| TFEB["TFEB"]
    MOTOR_NEURON -->|"activates"| ULK1["ULK1"]
    MOTOR_NEURON -->|"causes"| VESICLE_TRAFFICKING["VESICLE TRAFFICKING"]
    NEAT1["NEAT1"] -->|"expressed in"| MOTOR_NEURON
    MMP9["MMP9"] -->|"activates"| MOTOR_NEURON
    microglia["microglia"] -->|"activates"| MOTOR_NEURON
    glutamate["glutamate"] -->|"causes"| MOTOR_NEURON
    Amyotrophic_lateral_sclerosis["Amyotrophic lateral sclerosis"] -->|"causes"| MOTOR_NEURON
    CGAS["CGAS"] -->|"activates"| MOTOR_NEURON
    ALS["ALS"] -.protects against.-> MOTOR_NEURON
    ATAXIA["ATAXIA"] -->|"causes"| MOTOR_NEURON
    ATG7["ATG7"] -->|"causes"| MOTOR_NEURON
    AUTOPHAGY["AUTOPHAGY"] -->|"regulates"| MOTOR_NEURON

Outgoing (173)

Target	Relation	Type	Str
OLIGODENDROCYTES	expressed_in	cell_type	0.70
OLIGODENDROCYTES	associated_with	cell_type	0.70
NECROPTOSIS	activates	pathway	0.70
STING	expresses	gene	0.70
OLIGODENDROCYTE	expressed_in	cell_type	0.70
VCP	causes	gene	0.70
TLR4	activates	gene	0.70
TARDBP	activates	gene	0.70
STING	markers	gene	0.70
SOD1	regulates	gene	0.70
OLIGODENDROCYTE	associated_with	cell_type	0.70
OLIGODENDROCYTE	causes	cell_type	0.70
NEURONS	markers	cell_type	0.70
STING	stabilizes	gene	0.70
STING	associated_with	gene	0.70
NEURONS	associated_with	cell_type	0.70
PINK1	activates	gene	0.70
NECROPTOSIS	associated_with	pathway	0.70
NEURONS	disrupts	cell_type	0.70
TAU	disrupts	gene	0.70
VCP	interacts_with	gene	0.70
WNT	associated_with	gene	0.70
STING	causes	gene	0.70
VCP	activates	gene	0.65
VCP	associated_with	gene	0.65
NEURODEGENERATION	causes	disease	0.65
OPTN	causes	gene	0.65
SPINAL CORD	reduces	brain_region	0.65
NEURODEGENERATION	contributes_to	disease	0.65
SPINAL CORD	expressed_in	brain_region	0.65
RAPAMYCIN	interacts_with	drug	0.65
NEURONS	activates	cell_type	0.65
NEURODEGENERATION	biomarker_for	disease	0.65
ROS	activates	gene	0.65
NEURON	treats	cell_type	0.65
NEURON	transports	cell_type	0.65
NEURONS	transports	cell_type	0.65
NEURON	accumulates_in	cell_type	0.65
NEURONS	accumulates_in	cell_type	0.65
P53	causes	gene	0.65
NEURON	associated_with	cell_type	0.65
TNF	enhances	gene	0.60
NEURON	causes	cell_type	0.60
NEURON	activates	cell_type	0.60
SOD1	activates	gene	0.60
SOD1	causes	gene	0.60
NEUTROPHIL	activates	cell_type	0.60
SPINAL CORD	activates	brain_region	0.60
NEURONS	targets	cell_type	0.60
NEURON	enhances	cell_type	0.60

Incoming (300)

Source	Relation	Type	Str
ALS	associated_with	disease	0.95
TARDBP	expressed_in	protein	0.90
Tbk1 P.E696K	expressed_in	biomarker	0.85
TARDBP	associated_with	gene	0.85
Autophagolysosomal Dysfunction	expressed_in	process	0.85
NEAT1	expressed_in	gene	0.85
CHMP7	expressed_in	protein	0.85
SQSTM1	associated_with	gene	0.85
C9ORF72	toxic_to	gene	0.80
FUS toxicity	contributes_to	phenotype	0.80
PINK1-PRKN-dependent mitophagy	expressed_in	pathway	0.80
Honokiol	protects_against	compound	0.80
NDNF	expressed_in	protein	0.80
SNRPD1	expressed_in	gene	0.80
SOD1	protects_against	gene	0.80
SETX	expressed_in	gene	0.75
SLP2	expressed_in	protein	0.75
Pikfyve	expressed_in	protein	0.75
ASTROCYTE	associated_with	cell_type	0.70
ACHE	associated_with	gene	0.70
FUS	causes	gene	0.70
MICROGLIA	associated_with	cell_type	0.70
HTT	activates	gene	0.70
C9ORF72	regulates	gene	0.70
AMYOTROPHIC LATERAL SCLEROSIS	regulates	disease	0.70
MICROGLIA	expresses	cell_type	0.70
BDNF	expressed_in	gene	0.70
DOPAMINERGIC	expressed_in	cell_type	0.70
ASTROCYTE	interacts_with	cell_type	0.70
AMYOTROPHIC LATERAL SCLEROSIS	targets	disease	0.70
FRONTOTEMPORAL DEMENTIA	expresses	disease	0.70
AMYOTROPHIC LATERAL SCLEROSIS	markers	disease	0.70
MICROGLIA	disrupts	cell_type	0.70
C9ORF72	disrupts	gene	0.70
AMPK	activates	gene	0.70
HUNTINGTON'S DISEASE	associated_with	disease	0.70
AMYOTROPHIC LATERAL SCLEROSIS	expressed_in	disease	0.70
LAMP1	associated_with	gene	0.70
C9ORF72	transports	gene	0.70
microglia	activates	cell_type	0.70
MMP9	activates	protein	0.70
Amyotrophic lateral sclerosis	causes	disease	0.70
glutamate	causes	process	0.70
glutamate	activates	protein	0.70
ALS	associated_with	disease	0.65
JAK	associated_with	gene	0.65
ASTROCYTES	associated_with	cell_type	0.65
AMYOTROPHIC LATERAL SCLEROSIS	reduces	disease	0.65
JAK	activates	gene	0.65
AMYOTROPHIC LATERAL SCLEROSIS	impairs	disease	0.65

Targeting Hypotheses (28)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
SFPQ Paralog Displacement Triggers Cryptic Polyadenylation a	0.850	ALS	-
ATM Kinase Hyperactivation Triggers DNA Damage Response Over	0.842	ALS	-
GLE1-Mediated mRNA Export Defect Creates Translation-Compete	0.826	ALS	-
MATR3 Nuclear Body Disruption Impairs RNA Processing Hubs an	0.818	ALS	-
TIA1 Low-Complexity Domain Oxidation Drives Aberrant Stress	0.810	ALS	-

Microglial IFN-β Priming of Motor Neuron cGAS/STING Amplific	0.720	neurodegeneration	What determines the specificity of TDP-4
TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Ca	0.703	neurodegeneration	What mechanisms underlie neuronal resist
STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Functio	0.702	ALS	Causal Sequence of TDP-43 Nuclear Cleara
Metabolic Coupling Disruption Sensitizes Motor Neuron mPTP T	0.700	neurodegeneration	What determines the specificity of TDP-4
OPTN/TBK1 mutations create selective vulnerability by blocki	0.670	neurodegeneration	What are the neuron-specific effects of
Axonal Transport Defect: C9orf72 hexanucleotide expansion im	0.660	neurodegeneration	What are the neuron-specific effects of
CCL2-CCR2 myeloid signaling as a selective driver of fast-fa	0.626	neurodegeneration	CCL2-CCR2 Axis at NMJ: Mechanism of Sele
RNA-binding protein condensate maturation from reversible ph	0.626	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
Enhanced MCU Activity Primes mPTP Opening in Motor Neurons	0.620	neurodegeneration	What determines the specificity of TDP-4
Cell-state stratification is required to resolve CCL2-CCR2 A	0.612	neurodegeneration	CCL2-CCR2 Axis at NMJ: Mechanism of Sele
Cell-state stratification is required to resolve Causal Sequ	0.612	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Causal Sequence of TDP-43 Nuclear Cleara
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	CCL2-CCR2 Axis at NMJ: Mechanism of Sele
Impaired TFEB/TFE3 Nuclear Translocation Due to mTORC1 Hyper	0.603	neurodegeneration	What mechanisms underlie neuronal resist
PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5	0.584	neurodegeneration	How does PIKFYVE inhibition activate unc
Small-Molecule FUS Nuclear Import Correctors Rescue Motor Ne	0.550	neurodegeneration	Test Hypothesis Fixtures
TBK1 Loss Drives Motor Neuron Death Through Impaired Mitopha	0.525	ALS	What are the mechanisms by which microgl
Ferroptosis as Context-Dependent and Motor Neuron-Subtype Se	0.475	neurodegeneration	Is ferroptosis the primary driver of mot
Age-dependent downregulation of KPNA2 creates limbic neuron-	0.452	neurodegeneration	What mechanisms drive TDP-43 pathology s
Astrocyte-specific autophagy deficiency induces NADPH oxidas	0.380	ALS	How do non-cell autonomous effects of au
Ferroptosis as Primary Driver of Motor Neuron Death	0.339	neurodegeneration	Is ferroptosis the primary driver of mot
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote	0.000	ALS	-
TBK1 Loss Triggers eIF2α-Mediated Translational Repression T	0.000	ALS	What are the mechanisms by which microgl

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning MOTOR NEURON in their description or question text

MOTOR NEURON

Understanding Entity Pages

Summary

Pathway Diagram

Outgoing (173)

Incoming (300)

Targeting Hypotheses (28)

Mentioning Analyses (0)

Experiments (0)

Related Papers (0)

Debates (0)

Related Research

Microglial IFN-β Priming of Motor Neuron cGAS/STING Amplification

TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Cascade in Motor Neuro

STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Function Marker of TDP-43 N

Metabolic Coupling Disruption Sensitizes Motor Neuron mPTP Threshold

OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-inde

Axonal Transport Defect: C9orf72 hexanucleotide expansion impairs retrograde aut

CCL2-CCR2 myeloid signaling as a selective driver of fast-fatigable motor-neuron

RNA-binding protein condensate maturation from reversible phase separation to am

Enhanced MCU Activity Primes mPTP Opening in Motor Neurons

Cell-state stratification is required to resolve CCL2-CCR2 Axis at NMJ: Mechanis

Cell-state stratification is required to resolve Causal Sequence of TDP-43 Nucle

Perturbation-first validation should precede therapeutic claims for Causal Seque

Perturbation-first validation should precede therapeutic claims for CCL2-CCR2 Ax

Impaired TFEB/TFE3 Nuclear Translocation Due to mTORC1 Hyperactivity in Motor Ne

PIKFYVE Inhibition Activates Aggregate Exocytosis via PI(3,5)P2→TRPML1→Calcineur